Antibody
Ichorbio
Promo
Reset all filters

Min CHF:
Max CHF:
  1-30 of 5980
Supplier Product name Cat.no. Pack size Price
Alemtuzumab Biosimilar - Research Grade ICH4002-1MG ICH4002-5MG ICH4002-10MG ICH4002-25mg ICH4002-50MG ICH4002-100MG ICH4002-200MG ICH4002-500MG ICH4002-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
Matuzumab Biosimilar - Research Grade ICH4007-1MG ICH4007-5MG ICH4007-10MG ICH4007-25mg ICH4007-50MG ICH4007-100MG ICH4007-200MG ICH4007-500MG ICH4007-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
Trastuzumab Biosimilar - Research Grade ICH4013-1MG ICH4013-5MG ICH4013-10MG ICH4013-25mg ICH4013-50MG ICH4013-100MG ICH4013-200MG ICH4013-500MG ICH4013-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
Ado-Trastuzumab Emtansine Biosimilar - Research Grade ICH4014-5MG ICH4014-25mg ICH4014-200MG ICH4014-500MG ICH4014-1G 1'035,00 2'418,80 6'371,30 10'323,80 15'462,00
Aflibercept Biosimilar - Research Grade ICH4015-1MG ICH4015-5MG ICH4015-25mg ICH4015-200MG ICH4015-500MG ICH4015-1G 531,80 968,30 2'142,00 6'371,30 10'323,80 15'462,00
Pembrolizumab Biosimilar - Research Grade ICH4029-1MG ICH4029-5MG ICH4029-10MG ICH4029-25mg ICH4029-50MG ICH4029-100MG ICH4029-200MG ICH4029-500MG ICH4029-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
Ranibizumab Biosimilar - Research Grade ICH4031-1MG ICH4031-5MG ICH4031-10MG ICH4031-25mg ICH4031-50MG ICH4031-100MG ICH4031-200MG ICH4031-500MG ICH4031-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
Theralizumab Biosimilar - Research Grade ICH5023-1MG ICH5023-5MG ICH5023-10MG ICH5023-25mg ICH5023-50MG ICH5023-100MG ICH5023-200MG ICH5023-500MG ICH5023-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
Camrelizumab Biosimilar - Research Grade ICH5003-1MG ICH5003-5MG ICH5003-10MG ICH5003-25mg ICH5003-50MG ICH5003-100MG ICH5003-200MG ICH5003-500MG ICH5003-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
Durvalumab Biosimilar - Research Grade ICH5005-1MG ICH5005-5MG ICH5005-10MG ICH5005-25mg ICH5005-50MG ICH5005-100MG ICH5005-200MG ICH5005-500MG ICH5005-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
Sintilimab Biosimilar - Research Grade ICH5001-1MG ICH5001-5MG ICH5001-10MG ICH5001-25mg ICH5001-50MG ICH5001-100MG ICH5001-200MG ICH5001-500MG ICH5001-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
Tislelizumab Biosimilar - Research Grade ICH5004-1MG ICH5004-5MG ICH5004-10MG ICH5004-25mg ICH5004-50MG ICH5004-100MG ICH5004-200MG ICH5004-500MG ICH5004-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
Toripalimab Biosimilar - Research Grade ICH5002-1MG ICH5002-5MG ICH5002-10MG ICH5002-25mg ICH5002-50MG ICH5002-100MG ICH5002-200MG ICH5002-500MG ICH5002-1G 291,00 628,50 973,50 1'961,30 3'071,30 4'077,00 6'371,30 10'323,80 15'462,00
  1-30 of 5980

Customer Support
T +41 41 420 96 36
info@lucerna-chem.ch

Business Hours
Monday to Friday
08:00 – 12:00
13:00 – 17:00

Technical Support
tech@lucerna-chem.ch
Business Development
business.dev@lucerna-chem.ch

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern

© Copyright 2021 Lucerna-Chem AG, Switzerland

Order Conditions | Privacy Policy | Terms & Conditions | Impressum